<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01259609</url>
  </required_header>
  <id_info>
    <org_study_id>SNUH_OT</org_study_id>
    <nct_id>NCT01259609</nct_id>
  </id_info>
  <brief_title>Changes in Ciliary Body Thickness in Patients With Diabetic Macular Edema After Vitrectomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health &amp; Welfare, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether ciliary body thickness increased in the
      presence of diabetic macular edema and whether it changed after pars plana vitrectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A diabetic macular edema group consisted of diabetic patients who underwent PPV for diffuse
      diabetic macular edema. A epiretinal membrane group, a surgical control group, consisted of
      non-diabetic patients with epiretinal membrane who underwent pars plana vitrectomy. A healthy
      control was also included for the comparison of preoperative ciliary body thickness. Ciliary
      body thickness was measured using ultrasound biomicroscopy, and central macular thickness was
      determined using optical coherence tomography. The visual outcome, ciliary body thickness,
      and central macular thickness were compared between groups before and 1, 2, and 4 months
      after pars plana vitrectomy and the correlations between the central macular thickness and
      ciliary body thickness and best corrected visual acuity were determined.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ciliary body thickness</measure>
    <time_frame>up to four months after surgery</time_frame>
    <description>ciliary body thickness was determined using ultrasound biomicroscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>central macular thickness</measure>
    <time_frame>up to four months after surgery</time_frame>
    <description>central macular thickness was determined using optical coherence tomography</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Diabetic Macular Edema</condition>
  <arm_group>
    <arm_group_label>Diabetic Macular Edema Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Epiretinal Membrane Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pars Plana Vitrectomy</intervention_name>
    <description>25-gauge three-port pars plana vitrectomy</description>
    <arm_group_label>Diabetic Macular Edema Group</arm_group_label>
    <arm_group_label>Epiretinal Membrane Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for diabetic macular edema group:

          -  Diabetic macular edema with preoperative central macular thickness &gt; 300 Î¼m on optical
             coherence tomography

          -  Macular edema that was not associated with an epiretinal membrane or traction membrane

          -  No combined traction retinal detachment or vitreous hemorrhage

          -  No signs of ocular inflammatory disease on preoperative examination

          -  Phakic eye

          -  An axial length between 22.0 mm and 25.0 mm

        Exclusion Criteria for diabetic macular edema group:

          -  Patients with uveitis, inflammatory connective tissue disorders or a history of
             previous ocular surgery

          -  Long-term application of topical medication, a history of intravitreal steroid or
             anti-VEGF injection within 3 months before vitrectomy

        Inclusion Criteria for epiretinal membrane group:

          -  Non-diabetic patients with an epiretinal membrane who were scheduled for vitrectomy

          -  No ocular or systemic disease other than epiretinal membrane

        Inclusion Criteria for healthy group:

          -  No diabetes

          -  No ocular disease other than cataract
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyeong Gon Yu, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Ophthalmology, Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2010</study_first_submitted>
  <study_first_submitted_qc>December 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2010</study_first_posted>
  <last_update_submitted>December 13, 2010</last_update_submitted>
  <last_update_submitted_qc>December 13, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 14, 2010</last_update_posted>
  <responsible_party>
    <name_title>Hyeong Gon Yu</name_title>
    <organization>Department of Ophthalmology, Seoul National University Hospital, Seoul, Korea</organization>
  </responsible_party>
  <keyword>Diabetic Macular Edema</keyword>
  <keyword>Ciliary Body</keyword>
  <keyword>Ultrasound Biomicroscopy</keyword>
  <keyword>Vitrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Edema</mesh_term>
    <mesh_term>Macular Edema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

